Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression

• Published in: Cells (Basel, Switzerland) Vol. 13; no. 19; p. 1666
• Main Authors: Sabit, Hussein, Arneth, Borros, Abdel-Ghany, Shaimaa, Madyan, Engy F, Ghaleb, Ashraf H, Selvaraj, Periasamy, Shin, Dong M, Bommireddy, Ramireddy, Elhashash, Ahmed
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 09.10.2024; MDPI
• Subjects: Acidosis; Animals; Autophagy; Cancer therapies; Cell proliferation; Chemotherapy; Cytokines; Disease Progression; Endothelial cells; Extracellular matrix; Extracellular Matrix - metabolism; Extracellular Matrix - pathology; Genotype & phenotype; Growth factors; Hepatocytes; Humans; Hypoxia; Immunotherapy; Inflammation; Leukocytes (eosinophilic); Leukocytes (neutrophilic); Liver cancer; Liver Neoplasms - pathology; Lymphocytes; Macrophages; Mast cells; Medical prognosis; Medical research; Metabolism; Metabolites; Metastases; Metastasis; Monocytes; Morbidity; Mutation; Neoplasms - pathology; Phosphorylation; Protons; Public health; Respiration; Review; Stromal cells; Tumor cells; Tumor Microenvironment; Tumors; targeted therapy; liver cancer; tumor microenvironment; TME; ECM; immunotherapy
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells13191666

Liver cancer represents a substantial global health challenge, contributing significantly to worldwide morbidity and mortality. It has long been understood that tumors are not composed solely of cancerous cells, but also include a variety of normal cells within their structure. These tumor-associated normal cells encompass vascular endothelial cells, fibroblasts, and various inflammatory cells, including neutrophils, monocytes, macrophages, mast cells, eosinophils, and lymphocytes. Additionally, tumor cells engage in complex interactions with stromal cells and elements of the extracellular matrix (ECM). Initially, the components of what is now known as the tumor microenvironment (TME) were thought to be passive bystanders in the processes of tumor proliferation and local invasion. However, recent research has significantly advanced our understanding of the TME's active role in tumor growth and metastasis. Tumor progression is now known to be driven by an intricate imbalance of positive and negative regulatory signals, primarily influenced by specific growth factors produced by both inflammatory and neoplastic cells. This review article explores the latest developments and future directions in understanding how the TME modulates liver cancer, with the aim of informing the design of novel therapies that target critical components of the TME.